|
GB929401A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Encapsulated emulsions and processes for their preparation
|
|
GB929406A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
A process for the production of encapsulated material
|
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
|
US4760057A
(en)
*
|
1983-06-23 |
1988-07-26 |
Merck & Co., Inc. |
(Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
|
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
US4997443A
(en)
|
1985-08-26 |
1991-03-05 |
Hana Biologics, Inc. |
Transplantable artificial tissue and process
|
|
EP0305496A4
(en)
|
1987-03-17 |
1989-07-11 |
Insite Vision Inc |
TIMOLOL DERIVATIVES.
|
|
US4997652A
(en)
|
1987-12-22 |
1991-03-05 |
Visionex |
Biodegradable ocular implants
|
|
US5843156A
(en)
|
1988-08-24 |
1998-12-01 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel cellular therapy
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5681964A
(en)
|
1990-10-23 |
1997-10-28 |
University Of Kentucky Research Foundation |
Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
|
|
US5286495A
(en)
|
1992-05-11 |
1994-02-15 |
University Of Florida |
Process for microencapsulating cells
|
|
US5344701A
(en)
|
1992-06-09 |
1994-09-06 |
Minnesota Mining And Manufacturing Company |
Porous supports having azlactone-functional surfaces
|
|
US5506226A
(en)
|
1993-04-19 |
1996-04-09 |
Alcon Laboratories, Inc. |
Ethacrynic acid-like compounds and use thereof to treat glaucoma
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US6051576A
(en)
|
1994-01-28 |
2000-04-18 |
University Of Kentucky Research Foundation |
Means to achieve sustained release of synergistic drugs by conjugation
|
|
US5502092A
(en)
|
1994-02-18 |
1996-03-26 |
Minnesota Mining And Manufacturing Company |
Biocompatible porous matrix of bioabsorbable material
|
|
US5441722A
(en)
|
1994-02-18 |
1995-08-15 |
Merck & Co., Inc. |
Short synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-[C3 H3 ]-4[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide and related non radioactive compounds
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
ATE252894T1
(de)
|
1995-01-05 |
2003-11-15 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
|
US5612053A
(en)
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
|
US5612052A
(en)
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
|
US5624677A
(en)
|
1995-06-13 |
1997-04-29 |
Pentech Pharmaceuticals, Inc. |
Controlled release of drugs delivered by sublingual or buccal administration
|
|
US5916586A
(en)
|
1995-08-24 |
1999-06-29 |
Lever Brothers Company, Inc. |
Personal cleansing system comprising polymeric diamond-mesh bath sponge and liquid cleanser with deodorant composition
|
|
US5855615A
(en)
|
1996-06-07 |
1999-01-05 |
Menlo Care, Inc. |
Controller expansion sphincter augmentation media
|
|
US5866155A
(en)
|
1996-11-20 |
1999-02-02 |
Allegheny Health, Education And Research Foundation |
Methods for using microsphere polymers in bone replacement matrices and composition produced thereby
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
GB9704749D0
(en)
|
1997-03-07 |
1997-04-23 |
Univ London |
Tissue Implant
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
CA2221195A1
(en)
|
1997-11-14 |
1999-05-14 |
Chantal E. Holy |
Biodegradable polymer matrix
|
|
US6841617B2
(en)
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6818018B1
(en)
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
|
US6632457B1
(en)
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
|
JP2002531217A
(ja)
|
1998-12-04 |
2002-09-24 |
チャンドラシェカー ピー． パサック， |
生体適合性架橋ポリマー
|
|
US8008283B2
(en)
|
1998-12-23 |
2011-08-30 |
Neurotherapeutics Pharma, Inc. |
Methods and compositions for the treatment of neuropsychiatric disorders
|
|
US20040258763A1
(en)
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
IN192012B
(https=)
|
1999-03-19 |
2004-02-07 |
Vinod Chintamani Malshe |
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
AU4977800A
(en)
|
1999-04-26 |
2000-11-10 |
California Institute Of Technology |
(in situ) forming hydrogels
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
US6765019B1
(en)
|
1999-05-06 |
2004-07-20 |
University Of Kentucky Research Foundation |
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
|
|
US6333029B1
(en)
|
1999-06-30 |
2001-12-25 |
Ethicon, Inc. |
Porous tissue scaffoldings for the repair of regeneration of tissue
|
|
SE9904344D0
(sv)
|
1999-12-01 |
1999-12-01 |
Ralf Goeran Andersson |
Method of producing porous spherical particles
|
|
ATE331514T1
(de)
|
1999-12-22 |
2006-07-15 |
Sugen Inc |
Indolinonderivate zur abänderung der c-kit tyrosinproteinkinase
|
|
JP3663382B2
(ja)
|
2000-02-15 |
2005-06-22 |
スージェン・インコーポレーテッド |
ピロール置換２−インドリノン蛋白質キナーゼ阻害剤
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US6897201B2
(en)
|
2000-08-21 |
2005-05-24 |
Inspire Pharmaceuticals, Inc. |
Compositions and methods for the treatment of glaucoma or ocular hypertension
|
|
US7115585B2
(en)
*
|
2000-08-21 |
2006-10-03 |
Inspire Pharmaceuticals, Inc. |
Compositions for treating epithelial and retinal tissue diseases
|
|
ES2177415B1
(es)
|
2000-09-04 |
2004-10-16 |
Ragactives, S.L. |
Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.
|
|
CN1507357A
(zh)
|
2000-10-31 |
2004-06-23 |
PRҩƷ����˾ |
提高生物活性分子传递的方法和组合物
|
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
|
GB2370839A
(en)
|
2001-01-06 |
2002-07-10 |
Benedikt Timmerman |
Immunogenic complex useful for disease control
|
|
BR0102252B1
(pt)
|
2001-04-10 |
2013-10-22 |
|
Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
|
|
US20020183858A1
(en)
|
2001-06-05 |
2002-12-05 |
Contiliano Joseph H. |
Attachment of absorbable tissue scaffolds to scaffold fixation devices
|
|
ATE478656T1
(de)
|
2001-06-22 |
2010-09-15 |
Univ Johns Hopkins Med |
Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
|
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
AU2002350207A1
(en)
|
2001-11-19 |
2003-06-10 |
Control Delivery Systems, Inc. |
Topical delivery of codrugs
|
|
US20050164994A1
(en)
|
2001-12-10 |
2005-07-28 |
Control Deliver Systems, Inc. |
Treatment of genitourinary tract disorders
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
EP1549255A4
(en)
|
2002-09-13 |
2007-12-19 |
Coopervision Inc |
DEVICES AND METHOD FOR IMPROVING THE SEA THICKNESS
|
|
EP1542739B1
(en)
|
2002-09-26 |
2008-12-10 |
Angiotech International Ag |
Perivascular wraps
|
|
BR0316685A
(pt)
|
2002-12-17 |
2005-11-01 |
Nastech Pharm Co |
Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade
|
|
US7060299B2
(en)
|
2002-12-31 |
2006-06-13 |
Battelle Memorial Institute |
Biodegradable microparticles that stabilize and control the release of proteins
|
|
TW200500067A
(en)
|
2003-01-21 |
2005-01-01 |
Control Delivery Sys Inc |
Salts of codrugs and uses related thereto
|
|
GB0307011D0
(en)
|
2003-03-27 |
2003-04-30 |
Regentec Ltd |
Porous matrix
|
|
EP1633403A2
(en)
|
2003-05-21 |
2006-03-15 |
Control Delivery Systems, Inc. |
Codrugs of diclofenac
|
|
JP5628467B2
(ja)
|
2003-06-26 |
2014-11-19 |
シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． |
生体分解性徐放性ドラッグデリバリーシステム
|
|
DK1635875T3
(da)
|
2003-06-26 |
2009-01-12 |
Psivida Inc |
In-situ-geldannende lægemiddeladministrationssystem
|
|
AU2004260756B2
(en)
|
2003-07-30 |
2010-03-25 |
Kyowa Hakko Kirin Co., Ltd. |
Indazole derivatives
|
|
US7314959B2
(en)
|
2003-08-07 |
2008-01-01 |
Wisconsin Alumni Research Foundation |
Amino thiol compounds and compositions for use in conjunction with cancer therapy
|
|
US20090148527A1
(en)
|
2007-12-07 |
2009-06-11 |
Robinson Michael R |
Intraocular formulation
|
|
US20050175709A1
(en)
|
2003-12-11 |
2005-08-11 |
Baty Ace M.Iii |
Therapeutic microparticles
|
|
US7211275B2
(en)
|
2004-01-16 |
2007-05-01 |
Massachusetts Institute Of Technology |
Composite materials for controlled release of water soluble products
|
|
EP1713514B1
(en)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US8163030B2
(en)
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
|
US20050259221A1
(en)
|
2004-05-20 |
2005-11-24 |
Coopervision, Inc |
Corneal onlays and wavefront aberration correction to enhance vision
|
|
AU2005269800B8
(en)
|
2004-07-19 |
2011-12-01 |
Jazz Pharmaceuticals Therapeutics, Inc. |
Particulate constructs for release of active agents
|
|
WO2006044660A2
(en)
|
2004-10-14 |
2006-04-27 |
Vanderbilt University |
Functionalized solid lipid nanoparticles and methods of making and using same
|
|
EP1812017A2
(en)
|
2004-10-21 |
2007-08-01 |
Duke University |
Ophthamological drugs
|
|
WO2006060723A2
(en)
|
2004-12-03 |
2006-06-08 |
Vical Incorporated |
Methods for producing block copolymer/amphiphilic particles
|
|
AU2006206249A1
(en)
|
2005-01-21 |
2006-07-27 |
Nicox S.A. |
Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
|
|
US7691364B2
(en)
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
|
EP1868653A2
(en)
|
2005-04-12 |
2007-12-26 |
PSivida Inc. |
Hmgcoa reductase inhibitor codrugs and uses thereof
|
|
MX2007013200A
(es)
|
2005-04-22 |
2008-03-24 |
Johnson & Johnson |
Composicion de inmunoliposoma para el direccionamiento hacia un receptor de la celula her2.
|
|
EP1885335A1
(en)
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
|
KR101205481B1
(ko)
|
2005-06-17 |
2012-11-27 |
오스트레일리언뉴클리어사이언스앤드테크놀로지오거나이제이션 |
방출 가능한 도펀트를 함유한 입자
|
|
US7858609B2
(en)
|
2005-11-28 |
2010-12-28 |
Marinus Pharmaceuticals |
Solid ganaxolone formulations and methods for the making and use thereof
|
|
DE102005058979A1
(de)
|
2005-12-09 |
2007-06-21 |
Qiagen Gmbh |
Magnetische Polymerpartikel
|
|
CN101330934B
(zh)
|
2005-12-14 |
2013-03-20 |
Scil技术有限公司 |
一种用于骨再生的可模压的生物材料及其制备方法和用途
|
|
US7501179B2
(en)
|
2005-12-21 |
2009-03-10 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
|
EP1962803A1
(en)
|
2005-12-23 |
2008-09-03 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
JP5819579B2
(ja)
|
2006-01-13 |
2015-11-24 |
サーモディクス，インコーポレイティド |
薬物送達のためのマトリックスを含む微粒子
|
|
WO2007090793A1
(en)
|
2006-02-06 |
2007-08-16 |
Nicox S.A. |
Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
|
|
US7883520B2
(en)
|
2006-04-10 |
2011-02-08 |
Forsight Labs, Llc |
Corneal epithelial pocket formation systems, components and methods
|
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
EP1891941A1
(en)
|
2006-08-11 |
2008-02-27 |
OctoPlus Technologies B.V. |
Aqueous gels comprising microspheres
|
|
EP2061433B1
(en)
|
2006-09-08 |
2011-02-16 |
Johns Hopkins University |
Compositions for enhancing transport through mucus
|
|
WO2008033426A1
(en)
|
2006-09-12 |
2008-03-20 |
Psivida Inc. |
Injector apparatus and method of use
|
|
GB0619869D0
(en)
|
2006-10-07 |
2006-11-15 |
Regentec Ltd |
Porous particles
|
|
WO2008067127A2
(en)
|
2006-11-09 |
2008-06-05 |
Alcon Research, Ltd. |
Water insoluble polymer matrix for drug delivery
|
|
WO2008075155A2
(en)
|
2006-12-15 |
2008-06-26 |
Nicox S.A. |
Carbonic anhydrase inhibitors derivatives
|
|
GB0701896D0
(en)
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
|
AU2008214319A1
(en)
|
2007-02-06 |
2008-08-14 |
Incept, Llc |
Polymerization with precipitation of proteins for elution in physiological solution
|
|
WO2008112287A1
(en)
|
2007-03-12 |
2008-09-18 |
Nektar Therapeutics |
Oligomer-beta blocker conjugates
|
|
US8492334B2
(en)
|
2007-06-21 |
2013-07-23 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
CN101081206A
(zh)
|
2007-06-29 |
2007-12-05 |
济南康泉医药科技有限公司 |
一种含酪氨酸激酶抑制剂的抗癌药物组合物
|
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
WO2009030270A1
(en)
|
2007-09-03 |
2009-03-12 |
Novartis Ag |
Dihydroindole derivatives useful in parkinson's disease
|
|
WO2009035565A1
(en)
|
2007-09-07 |
2009-03-19 |
Qlt Plug Delivery, Inc |
Prostaglandin analogues for implant devices and methods
|
|
EP2207577B1
(en)
*
|
2007-10-26 |
2015-01-14 |
National Institute Of Immunology |
Biodegradable polymer scaffold and process for preparation thereof
|
|
US8414646B2
(en)
|
2007-12-27 |
2013-04-09 |
Forsight Labs, Llc |
Intraocular, accommodating lens and methods of use
|
|
US8167941B2
(en)
|
2008-01-03 |
2012-05-01 |
Forsight Labs, Llc |
Intraocular, accommodating lens and methods of use
|
|
WO2009089070A2
(en)
|
2008-01-10 |
2009-07-16 |
The Johns Hopkins University |
Compositions and methods for reducing particle penetration through mucus
|
|
WO2009100176A2
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
|
WO2009107753A1
(ja)
|
2008-02-29 |
2009-09-03 |
財団法人 名古屋産業科学研究所 |
後眼部到達用リポソーム及び後眼部疾患用医薬組成物
|
|
ITMI20080382A1
(it)
|
2008-03-07 |
2009-09-08 |
Ctg Pharma S R L |
Composizioni farmaceutiche oculari
|
|
WO2009131794A1
(en)
|
2008-03-27 |
2009-10-29 |
University Of Kentucky Research Foundation |
Opioid-ketamine and norketamine codrug combinations for pain management
|
|
US8710069B2
(en)
|
2008-03-27 |
2014-04-29 |
University Of Kentucky Research Foundation |
Opioid-nornicotine codrugs combinations for pain management
|
|
US9125735B2
(en)
|
2008-04-04 |
2015-09-08 |
Forsight Labs, Llc |
Method of correcting vision using corneal onlays
|
|
WO2009132265A2
(en)
|
2008-04-25 |
2009-10-29 |
The University Of North Carolina At Chapel Hill |
Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
|
|
US8993615B2
(en)
|
2008-08-08 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for treatment of neurodegenerative disease
|
|
WO2010030739A1
(en)
|
2008-09-10 |
2010-03-18 |
Abbott Laboratories |
Polyethylene glycol lipid conjugates and uses thereof
|
|
US9161903B2
(en)
|
2008-10-31 |
2015-10-20 |
Warsaw Orthopedic, Inc. |
Flowable composition that hardens on delivery to a target tissue site beneath the skin
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US20100143479A1
(en)
|
2008-12-04 |
2010-06-10 |
Oakwood Laboratories, Llc |
Method of making sustained release microparticles
|
|
CA2752419A1
(en)
|
2009-01-12 |
2010-07-15 |
Hadasit Medical Research Services & Development Limited |
Tissue regeneration membrane
|
|
EP2389371A4
(en)
|
2009-01-22 |
2012-09-12 |
Neurotherapeutics Pharma Inc |
ANALOGUES OF BUMETANIDE, FUROSEMIDE, PIRETANIDE, AZOSEMIDE AND TORSEMID, AND RELATED COMPOSITIONS AND METHODS OF USE
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2010091187A2
(en)
|
2009-02-04 |
2010-08-12 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
|
WO2010093662A2
(en)
|
2009-02-10 |
2010-08-19 |
Psivida Us, Inc. |
Ocular trocar assembly
|
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
|
US20100227905A1
(en)
|
2009-03-03 |
2010-09-09 |
Alcon Research, Ltd. |
Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
|
|
GB0903810D0
(en)
|
2009-03-05 |
2009-04-22 |
Regentec Ltd |
Delivery system
|
|
NZ595185A
(en)
|
2009-03-27 |
2012-11-30 |
Australian Nuclear Science Tec |
Triggered release of a compound or composition into solution using porus particles
|
|
WO2010114770A1
(en)
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
WO2010129545A2
(en)
|
2009-05-04 |
2010-11-11 |
Psivida Us, Inc. |
Porous silicon drug-eluting particles
|
|
CA3149284A1
(en)
|
2009-12-15 |
2011-07-14 |
Incept, Llc |
Implants and biodegradable fiducial markers
|
|
WO2011106702A2
(en)
*
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
WO2011109384A2
(en)
|
2010-03-02 |
2011-09-09 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
|
US9162981B2
(en)
|
2010-03-23 |
2015-10-20 |
The Johns Hopkins University |
Compositions and methods for treatment of neurodegenerative disease
|
|
ES2691671T3
(es)
|
2010-06-24 |
2018-11-28 |
Alkermes Pharma Ireland Limited |
Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
|
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
|
US20150056300A1
(en)
|
2010-10-22 |
2015-02-26 |
Bind Therapeutics, Inc. |
Therapeutic nanoparticles with high molecular weight copolymers
|
|
WO2012061703A1
(en)
|
2010-11-05 |
2012-05-10 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
JP6009457B2
(ja)
|
2010-12-23 |
2016-10-19 |
ネクター セラピューティクス |
ポリマー−デスエチルスニチニブコンジュゲート
|
|
US9827326B2
(en)
|
2010-12-23 |
2017-11-28 |
Nektar Therapeutics |
Polymer-sunitinib conjugates
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
US9382229B2
(en)
|
2011-02-15 |
2016-07-05 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
|
CN103561748A
(zh)
|
2011-04-07 |
2014-02-05 |
苏坎波公司 |
治疗眼疲劳的方法
|
|
KR20140038404A
(ko)
|
2011-04-12 |
2014-03-28 |
가부시키가이샤 아루떼꾸 우에노 |
수성 안과용 조성물
|
|
MX356528B
(es)
|
2011-05-11 |
2018-06-01 |
Apellis Pharmaceuticals Inc |
Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y usos de los mismos.
|
|
JP5989780B2
(ja)
|
2011-09-14 |
2016-09-07 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼挿入装置および方法
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
JP6199883B2
(ja)
|
2011-12-05 |
2017-09-20 |
インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ |
医療用オルガノゲルプロセス及び組成物
|
|
BR112014014262A2
(pt)
|
2011-12-14 |
2017-06-13 |
Univ Johns Hopkins |
nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
|
|
EP2804632B1
(en)
|
2012-01-19 |
2019-09-18 |
The Johns Hopkins University |
Nanoparticle formulations with enhanced mucosal penetration
|
|
BR112014017969A8
(pt)
|
2012-01-23 |
2017-07-11 |
Allergan Inc |
Microesferas ou micropartículas bioerodíveis ou bio-degradáveis liberadas por tempo suspensas em uma formulação de droga injetável de formação de depósito
|
|
JP6138904B2
(ja)
|
2012-03-16 |
2017-05-31 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
|
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
|
AR092821A1
(es)
|
2012-04-20 |
2015-05-06 |
Sucampo Ag |
Conjugado de derivado de acido graso-polimero
|
|
CN111700879A
(zh)
|
2012-05-03 |
2020-09-25 |
卡拉制药公司 |
显示提高的粘膜转移的药物纳米粒子
|
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
|
AU2013256008B2
(en)
|
2012-05-04 |
2016-02-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
|
CN104271566B
(zh)
|
2012-05-22 |
2017-05-31 |
霍夫曼-拉罗奇有限公司 |
取代的联吡啶胺及其用途
|
|
WO2013177367A2
(en)
|
2012-05-23 |
2013-11-28 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
|
WO2013188283A1
(en)
|
2012-06-12 |
2013-12-19 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing sunitinib
|
|
EP2895146A1
(en)
|
2012-09-17 |
2015-07-22 |
BIND Therapeutics, Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
CN103833998B
(zh)
|
2012-11-26 |
2017-10-27 |
杨子剑 |
含有利尿酸结构的新化合物以及制备方法和用途
|
|
CN103897174A
(zh)
|
2012-12-26 |
2014-07-02 |
杨子剑 |
含有利尿酸结构的新聚合物以及制备方法和用途
|
|
US9044319B2
(en)
|
2013-03-01 |
2015-06-02 |
Cormatrix Cardiovascular, Inc. |
Anchored cardiovascular valve
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
CN104059054B
(zh)
|
2013-03-19 |
2018-11-20 |
浙江导明医药科技有限公司 |
用于治疗癌症的三级环状胺alk激酶抑制剂
|
|
AU2014248460B2
(en)
|
2013-04-01 |
2019-04-11 |
Allergan, Inc. |
Microsphere drug delivery system for sustained intraocular release
|
|
JP6523251B2
(ja)
|
2013-05-01 |
2019-05-29 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｃ−結合ヘテロシクロアルキル置換ピリミジン類及びそれらの用途
|
|
CN104208715B
(zh)
|
2013-05-31 |
2016-12-28 |
天津键凯科技有限公司 |
具有提高的药物生物活性的低分子量聚乙二醇药物结合物
|
|
DK2848262T3
(da)
|
2013-09-12 |
2021-02-08 |
Smartdyelivery Gmbh |
Cellespecifik målretning ved hjælp af nanostrukturerede bærersystemer
|
|
US20150099802A1
(en)
|
2013-10-03 |
2015-04-09 |
Sucampo Ag |
Selective tumor treatment
|
|
US9655862B2
(en)
|
2013-10-29 |
2017-05-23 |
Shaker A. Mousa |
Ocular nanoformulation and method of use in angiogenesis-mediated disorders
|
|
DK3071248T3
(da)
|
2013-11-19 |
2020-11-09 |
Univ Cornell |
Vævsstilladsmateriale til vævsregenerering og fremgangsmåder til fremstilling
|
|
CA2933900A1
(en)
|
2013-12-20 |
2015-06-25 |
Georgia Tech Research Corporation |
Formulations and methods for targeted ocular delivery of therapeutic agents
|
|
KR101564401B1
(ko)
|
2014-04-10 |
2015-11-02 |
한국화학연구원 |
브린졸아마이드의 제조방법
|
|
ES2966886T3
(es)
*
|
2014-05-09 |
2024-04-24 |
Univ Yale |
Partículas recubiertas con poliglicerol hiperramificado y métodos de elaboración y uso de las mismas
|
|
CA2957764C
(en)
|
2014-08-13 |
2019-07-02 |
The Johns Hopkins University |
Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularization
|
|
US20160106587A1
(en)
|
2014-10-16 |
2016-04-21 |
Incept, Llc |
Ocular gels or hydrogels and microinjectors
|
|
WO2016065245A1
(en)
|
2014-10-24 |
2016-04-28 |
Incept, Llc |
Extra luminal scaffold
|
|
AU2015360469B2
(en)
|
2014-12-10 |
2021-03-25 |
Incept, Llc |
Hydrogel drug delivery implants
|
|
JP6847848B2
(ja)
*
|
2014-12-15 |
2021-03-24 |
ザ ジョーンズ ホプキンズ ユニバーシティＴｈｅ Ｊｏｈｎｓ Ｈｏｐｋｉｎｓ Ｕｎｉｖｅｒｓｉｔｙ |
スニチニブ製剤、及び緑内障の治療におけるその使用方法
|
|
JP6479485B2
(ja)
|
2015-01-15 |
2019-03-06 |
大内新興化学工業株式会社 |
眼疾患治療用ナノ粒子製剤
|
|
US20180008718A1
(en)
|
2015-01-20 |
2018-01-11 |
The Johns Hopkins University |
Compositions for the sustained release of anti-glaucoma agents to control intraocular pressure
|
|
US20160324836A1
(en)
|
2015-05-05 |
2016-11-10 |
pSivida US.Inc. |
Injectable depot formulations
|
|
EP4279064A3
(en)
|
2015-05-12 |
2024-02-28 |
Incept, LLC |
Drug delivery from hydrogels
|
|
EP3324902B1
(en)
|
2015-07-22 |
2024-12-18 |
Incept, LLC |
Coated punctal plug
|
|
KR20180058758A
(ko)
*
|
2015-09-22 |
2018-06-01 |
그레이버그 비젼, 인크. |
안구 장애의 치료를 위한 화합물 및 조성물
|
|
HK1257499A1
(zh)
*
|
2015-11-12 |
2019-10-25 |
Graybug Vision, Inc. |
用於治疗的聚集性微粒
|
|
AU2016361579B2
(en)
|
2015-11-25 |
2022-08-04 |
Incept, Llc |
Shape changing drug delivery devices and methods
|
|
EP3600324A4
(en)
|
2017-03-23 |
2020-12-09 |
Graybug Vision, Inc. |
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS
|
|
CA3083805A1
(en)
|
2017-12-14 |
2019-06-20 |
Graybug Vision, Inc. |
Drugs and compositions for ocular delivery
|
|
WO2019209883A1
(en)
|
2018-04-23 |
2019-10-31 |
Graybug Vision, Inc. |
Improved continuous microparticle manufacture
|
|
WO2019210215A1
(en)
|
2018-04-26 |
2019-10-31 |
Graybug Vision, Inc. |
Drugs to treat ocular disorders
|
|
WO2020069353A1
(en)
|
2018-09-27 |
2020-04-02 |
Graybug Vision, Inc. |
Compounds and compositions for ocular delivery
|
|
WO2020102758A1
(en)
|
2018-11-15 |
2020-05-22 |
Graybug Vision, Inc. |
Improved aggregated microparticles
|